SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-29
👔
Editas Medicine, Inc.
@EDIT_InsiderForm 4 Filing: Burkly Linda Sells $13,157.76 of $EDIT
INSIDER SALE
⚡ MATERIALITY: 4/10
corporate issuer
Editas Medicine, Inc.
Ticker: $EDIT
Transaction Value
$13,157.76
Price/Share: $2.67
transaction date
2026-07-28
Shares: 4,928
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Burkly Linda, holds the title of EVP, CHIEF SCIENTIFIC OFFICER at Editas Medicine, Inc..
On 2026-07-28, the insider transacted 4,928 shares.The shares were transacted at a weighted average price of $2.67 per share, resulting in a total market-relevant value of $13,157.76.
Executive Summary Summary
Burkly Linda (EVP, CHIEF SCIENTIFIC OFFICER) sold $13K of $EDIT
Post-Transaction Position: 62,369 shares
SEC Accession No: 0001650664-26-000076 (CIK: 1985604)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.